The renowned laboratory service provider reported adjusted earnings of $3.50 in the last reported quarter, topping the Zacks ...

We recently compiled a list of the 7 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where ...

"Seeing is believing," the founder of lab company Truvian told me. So I tried its tabletop blood testing device—which ...

Barclays analyst Luke Sergott raised the firm’s price target on Labcorp (LH) to $271 from $249 and keeps an Equal Weight rating on the shares.

Labcorp Holdings Inc. (NYSE:LH), a prominent $20.8 billion healthcare diagnostics company, announced today an expansion of its credit facilities, underscoring the company's ongoing financial strategy.

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, has once again been named to ...

Supreme Court agrees to consider stopping class action lawsuit that accuses Labcorp Holdings unit of discrimination because ...

Holdings, widely known as LabCorp, has reached a new 52-week high, with its stock price soaring to $248.69. With a market ...

Labcorp Holdings Inc. closed 1.61% short of its 52-week high of $247.99, which the company reached on November 11th.

Jim Cramer, host of Mad Money, shared his thoughts on factors that could lead to market growth in 2025, pointing out some key ...

Discover the top genomics startups revolutionizing genome sequencing technologies to enhance disease prevention and treatment ...

On January 6, 2025, the United States Court of Appeals for the Federal Circuit (“CAFC”) affirmed the decision of the Patent Trial and Appeal ...